GO:0004415 hyalurononglucosaminidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004415 hyalurononglucosaminidase activity is a molecular function defined as the catalysis of random hydrolysis of (1->4) linkages between N-acetyl-beta-D-glucosamine and D-glucuronate residues in hyaluronate.
• This activity is synonymous with hyaluronidase, chondroitinase, and hyaluronoglucosidase activities, reflecting a broad specificity for glycosaminoglycan substrates.
• Hyalurononglucosaminidase activity is critical for extracellular matrix turnover, tissue remodeling, and inflammation, and its dysregulation is implicated in fibrosis and cancer.
• Research into this activity often employs knockout and overexpression models to dissect its role in carotid fibrosis and vascular injury responses.
• The enzyme's random hydrolysis mechanism distinguishes it from processive exoglycosidases, generating a broad range of hyaluronan fragments with diverse signaling functions.
• Studying GO:0004415 requires integrating biochemical assays, genetic models, and advanced omics to link molecular function to disease phenotypes.
Description
Hyalurononglucosaminidase activity (GO:0004415) is a molecular function that catalyzes the random hydrolysis of (1->4) linkages between N-acetyl-beta-D-glucosamine and D-glucuronate residues in hyaluronate. This activity is essential for the degradation of hyaluronic acid, a major component of the extracellular matrix, and is performed by enzymes commonly known as hyaluronidases. Researchers study this term to understand how extracellular matrix remodeling contributes to physiological processes such as wound healing and pathological conditions including fibrosis and cancer. The random cleavage mechanism generates hyaluronan fragments of varying sizes, which can act as signaling molecules in inflammation and tissue repair. Consequently, GO:0004415 is a focal point for investigations into matrix biology, vascular injury, and therapeutic interventions targeting hyaluronidase enzymes.
hyalurononglucosaminidase activity At A Glance
| GO ID | GO:0004415 |
|---|---|
| GO term | hyalurononglucosaminidase activity |
| Ontology | molecular_function |
| Synonym | chondroitinase activity, chondroitinase I activity, hyaluronate 4-glycanohydrolase activity, hyaluronidase activity, hyaluronoglucosaminidase activity, hyaluronoglucosidase activity |
| Major function | Random hydrolysis of (1->4) linkages between N-acetyl-beta-D-glucosamine and D-glucuronate residues in hyaluronate |
| Substrate | Hyaluronate (hyaluronic acid) and related glycosaminoglycans |
| Reaction type | Hydrolytic cleavage of glycosidic bonds |
| Biological context | Extracellular matrix turnover, tissue remodeling, inflammation |
What Is GO:0004415?
GO:0004415 hyalurononglucosaminidase activity is defined as the catalysis of the random hydrolysis of (1->4) linkages between N-acetyl-beta-D-glucosamine and D-glucuronate residues in hyaluronate. In simpler terms, it is an enzymatic function that breaks down hyaluronic acid by randomly cutting the bonds between its sugar units. This activity is also known by synonyms such as hyaluronidase, chondroitinase, and hyaluronoglucosidase, indicating its ability to act on related glycosaminoglycans.
Why Is hyalurononglucosaminidase activity Important in Cell Biology?
Hyalurononglucosaminidase activity is crucial for maintaining extracellular matrix homeostasis and facilitating tissue remodeling, and its dysregulation is linked to a range of diseases including fibrosis, cancer, and inflammatory disorders. Understanding this activity provides insights into fundamental matrix biology and offers potential targets for therapeutic intervention in conditions characterized by abnormal hyaluronan accumulation or degradation.
• Regulates extracellular matrix turnover by degrading hyaluronic acid, influencing tissue hydration and elasticity.
• Plays a role in inflammation by generating hyaluronan fragments that act as signaling molecules.
• Implicated in fibrosis, where excessive matrix deposition and altered hyaluronidase activity contribute to pathology.
• Associated with cancer progression, as hyaluronan fragments can promote tumor cell migration and angiogenesis.
• Essential for normal physiological processes such as wound healing and embryonic development.
• Serves as a target for therapeutic enzymes in conditions like vitreous hemorrhage and drug delivery.
• Involved in vascular injury responses, with strain-selective effects observed in mouse models.
• Provides a model for studying enzyme kinetics and substrate specificity in glycosaminoglycan biology.
Molecular Mechanism of hyalurononglucosaminidase activity
Substrate Recognition and Binding
In simple terms: The enzyme first grabs onto hyaluronic acid, a long sugar chain in the extracellular matrix.
Hyalurononglucosaminidase enzymes recognize and bind to hyaluronate, a glycosaminoglycan composed of repeating disaccharide units of N-acetyl-beta-D-glucosamine and D-glucuronate. The binding involves electrostatic interactions between positively charged residues in the enzyme's active site and the negatively charged carboxylate groups of the substrate. This initial recognition ensures specificity for hyaluronate over other glycosaminoglycans, although some enzymes exhibit cross-reactivity with chondroitin sulfate.
Catalytic Hydrolysis
In simple terms: The enzyme then cuts the sugar chain at random points by adding water, breaking the bonds between sugars.
The catalytic mechanism involves the random hydrolysis of (1->4) glycosidic linkages between N-acetyl-beta-D-glucosamine and D-glucuronate residues. This is achieved through a general acid-base catalysis mechanism, where a proton donor and a nucleophile in the active site facilitate the cleavage of the glycosidic bond, resulting in the formation of a reducing end and a non-reducing end. The random nature of the cleavage means that the enzyme does not processively degrade the chain from one end but instead cuts at multiple sites, generating a heterogeneous mixture of hyaluronan fragments.
Cofactors and Optimal Conditions
In simple terms: The enzyme works best under certain conditions, like specific pH and salt levels, and may need helper molecules.
Hyalurononglucosaminidase activity typically requires an acidic pH for optimal function, although some enzymes are active at neutral pH. While many hyaluronidases do not require metal cofactors, some bacterial enzymes are known to be metalloenzymes that depend on divalent cations such as calcium or magnesium for activity. The activity can be modulated by ionic strength and the presence of other matrix components.
Regulation of Activity
In simple terms: The enzyme's activity is controlled by various factors, including inhibitors and gene expression changes.
Hyalurononglucosaminidase activity is regulated at multiple levels, including transcriptional control of hyaluronidase genes, post-translational modifications, and the presence of endogenous inhibitors such as hyaluronidase inhibitor. In pathological conditions like fibrosis, altered expression of hyaluronidases and their inhibitors can lead to imbalanced hyaluronan turnover. Additionally, inflammatory cytokines can induce hyaluronidase expression, linking this activity to immune responses.
Key Genes Involved in GO:0004415 hyalurononglucosaminidase activity
The following genes encode proteins that exhibit hyalurononglucosaminidase activity or are directly involved in its regulation and function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HYAL1 | Encodes a lysosomal hyaluronidase with hyalurononglucosaminidase activity | Studied in cancer and lysosomal storage disorders |
| HYAL2 | Encodes a GPI-anchored hyaluronidase that degrades high-molecular-weight hyaluronan | Implicated in tumor suppression and inflammation |
| HYAL3 | Encodes a hyaluronidase-like protein with unclear catalytic activity | Potential role in sperm function and fertilization |
| HYAL4 | Encodes a chondroitinase with specificity for chondroitin sulfate | Investigated in connective tissue biology |
| HYAL5 | Encodes a sperm-associated hyaluronidase | Important for fertilization in some species |
| SPAM1 | Encodes PH-20, a sperm hyaluronidase involved in fertilization | Target for contraceptive research |
| CEMIP | Encodes a hyaluronidase involved in hyaluronan degradation and cell migration | Linked to cancer metastasis and inflammation |
| TMEM2 | Encodes a transmembrane protein with hyaluronidase activity | Regulates hyaluronan turnover in development |
| HABP2 | Encodes a hyaluronan-binding protease | May modulate hyaluronidase activity in coagulation |
| ITIH1 | Encodes inter-alpha-trypsin inhibitor heavy chain 1 | Forms complexes with hyaluronan and modulates its degradation |
| ITIH2 | Encodes inter-alpha-trypsin inhibitor heavy chain 2 | Similar to ITIH1, involved in matrix stabilization |
| ITIH3 | Encodes inter-alpha-trypsin inhibitor heavy chain 3 | Potential role in hyaluronan metabolism |
| ITIH4 | Encodes inter-alpha-trypsin inhibitor heavy chain 4 | Associated with inflammation and matrix remodeling |
| HAS1 | Encodes hyaluronan synthase 1 | Synthesizes hyaluronan, opposing hyaluronidase activity |
| HAS2 | Encodes hyaluronan synthase 2 | Major producer of hyaluronan in tissues |
| HAS3 | Encodes hyaluronan synthase 3 | Produces hyaluronan with distinct size distribution |
| CD44 | Encodes a hyaluronan receptor | Mediates cellular responses to hyaluronan fragments |
| TLR4 | Encodes Toll-like receptor 4 | Recognizes hyaluronan fragments as danger signals |
How Is hyalurononglucosaminidase activity Regulated?
Hyalurononglucosaminidase activity is regulated through transcriptional and post-translational mechanisms, as well as by endogenous inhibitors and substrate availability. Inflammatory cytokines such as TNF-alpha and IL-1beta can upregulate hyaluronidase expression, while hypoxia and growth factors modulate activity in the tumor microenvironment. Additionally, the activity can be influenced by the presence of hyaluronan-binding proteins and the molecular weight of the substrate.
hyalurononglucosaminidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HYAL1 | Cancer, lysosomal storage disorders | Knockout mice, tumor xenografts |
| HYAL2 | Cancer, inflammation | Overexpression cell lines, knockout models |
| CEMIP | Cancer metastasis, inflammation | Knockdown and knockout models |
| TMEM2 | Developmental disorders, matrix turnover | Zebrafish and mouse knockouts |
| CD44 | Inflammation, cancer | Knockout mice, blocking antibodies |
Hyalurononglucosaminidase activity in Fibrosis
Dysregulated hyalurononglucosaminidase activity contributes to fibrosis by altering hyaluronan turnover, leading to excessive matrix deposition and tissue stiffening. In a mouse model of carotid injury, strain-selective efficacy of sacubitril/valsartan was observed on carotid fibrosis, highlighting the interplay between hyaluronidase activity and vascular remodeling. Targeting hyaluronidases may offer therapeutic benefits in fibrotic diseases.
Hyalurononglucosaminidase activity in Cancer
In cancer, elevated hyaluronidase activity promotes tumor progression by generating hyaluronan fragments that stimulate angiogenesis, inflammation, and metastasis. Hyaluronidases such as HYAL1 and CEMIP are often overexpressed in tumors and correlate with poor prognosis. Inhibiting these enzymes is being explored as an anti-cancer strategy.
Hyalurononglucosaminidase activity in Inflammation
Hyaluronan fragments produced by hyalurononglucosaminidase activity act as danger-associated molecular patterns that activate immune cells via TLR4 and CD44, exacerbating inflammatory responses. This has been implicated in conditions such as arthritis, colitis, and sepsis. Modulating hyaluronidase activity could therefore have anti-inflammatory effects.
From hyalurononglucosaminidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of HYAL1 affect tumor growth? | HYAL1 knockout cell lines and mouse xenografts |
| What is the role of HYAL2 in inflammation? | HYAL2 knockout mice and macrophage-specific deletion |
| How does point mutation in the active site affect enzyme activity? | CRISPR point-mutation knock-in of catalytic residues |
| Can tagged HYAL1 be used to track localization? | Knock-in of fluorescent or epitope tags |
| Does overexpression of CEMIP promote metastasis? | CEMIP overexpression in cancer cell lines |
| What is the impact of hyaluronidase on fibrosis? | Strain-selective mouse models of vascular injury |
How to Study the hyalurononglucosaminidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Turbidimetric assay | Hyaluronidase activity by hyaluronan precipitation | Quantifying enzyme activity in tissue extracts |
| Fluorogenic assay | Release of fluorescently labeled hyaluronan fragments | High-throughput screening of inhibitors |
| Zymography | Active hyaluronidase species by molecular weight | Detecting isoforms in biological samples |
| CRISPR knockout | Loss of gene function | Studying physiological roles of hyaluronidases |
| Overexpression | Gain of function | Assessing oncogenic potential |
| RNA-seq | Transcriptional changes | Identifying pathways affected by hyaluronidase modulation |
| Proteomics | Protein expression and modifications | Discovering interacting partners |
| Confocal imaging | Spatial distribution of hyaluronan | Visualizing matrix remodeling |
Biochemical Assays for Hyaluronidase Activity
Hyalurononglucosaminidase activity can be measured using turbidimetric, colorimetric, or fluorogenic assays that detect the degradation of hyaluronan. These assays typically use hyaluronan substrates and measure the release of reducing ends or the decrease in viscosity. Zymography with hyaluronan-embedded gels allows visualization of active enzymes.
Genetic Approaches to Study Hyaluronidases
Knockout and transgenic mouse models, as well as CRISPR-Cas9 edited cell lines, are used to dissect the physiological roles of hyaluronidases. For example, strain-selective effects of sacubitril/valsartan on carotid fibrosis were studied in two inbred mouse strains, demonstrating the importance of genetic background. Overexpression and knockdown studies in cell culture provide complementary insights.
Omics and Imaging Techniques
RNA-seq and proteomics can reveal expression changes in hyaluronidases and related matrix genes under different conditions. Imaging techniques such as confocal microscopy with fluorescent hyaluronan-binding proteins can visualize hyaluronan distribution and degradation in tissues. These methods help link molecular activity to cellular phenotypes.
How CRISPR Can Be Used to Study GO:0004415 hyalurononglucosaminidase activity
Knockout
CRISPR-Cas9 knockout of hyaluronidase genes such as HYAL1 or HYAL2 in cell lines and mouse models enables the study of their loss-of-function phenotypes, including effects on hyaluronan accumulation, cell migration, and tumor growth. These models are essential for validating the role of hyalurononglucosaminidase activity in fibrosis and cancer.
Point Mutation
Introducing point mutations in catalytic residues of hyaluronidases via CRISPR base editing or homology-directed repair allows researchers to dissect the enzymatic activity from other functions. For example, mutating the active-site glutamate or aspartate can abolish hydrolysis while preserving substrate binding, revealing non-catalytic roles.
Knock-in
Knock-in of epitope tags, fluorescent proteins, or reporter genes into endogenous hyaluronidase loci using CRISPR facilitates real-time tracking of enzyme expression, localization, and dynamics. This approach is valuable for understanding how hyaluronidases are regulated in vivo.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of hyaluronidases can model the elevated enzyme levels seen in cancer and inflammatory diseases. These gain-of-function models help identify downstream effects on matrix remodeling and cell signaling.
How EDITGENE Supports hyalurononglucosaminidase activity Research
Researchers studying hyalurononglucosaminidase activity-related genes often need to determine whether a candidate gene is causally involved in matrix remodeling, fibrosis, or cancer. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell and animal models, enabling rigorous functional studies of GO:0004415 and its associated pathways.
Contact EDITGENE today to design your custom CRISPR model for hyalurononglucosaminidase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| OGA Knockout HEK293 Cell Line | EDJ-KQ2049 | Human | 10724 | Details Get a Quote |
| HYAL1 Knockout HEK293 Cell Line | EDJ-KQ2118 | Human | 3373 | Details Get a Quote |
| CEMIP2 Knockout HEK293 Cell Line | EDJ-KQ3068 | Human | 23670 | Details Get a Quote |
| HYAL2 Knockout HEK293 Cell Line | EDJ-KQ5631 | Human | 8692 | Details Get a Quote |
| HYAL4 Knockout HEK293 Cell Line | EDJ-KQ8065 | Human | 23553 | Details Get a Quote |
| CEMIP Knockout HEK293 Cell Line | EDJ-KQ12153 | Human | 57214 | Details Get a Quote |
| SPAM1 Knockout HEK293 Cell Line | EDJ-KQ15429 | Human | 6677 | Details Get a Quote |
| HYAL1 Knockout HeLa Cell Line | EDJ-KQ20959 | Human | 3373 | Details Get a Quote |
| OGA Knockout A-549 Cell Line | EDJ-KQ22103 | Human | 10724 | Details Get a Quote |
| OGA Knockout HCT 116 Cell Line | EDJ-KQ22104 | Human | 10724 | Details Get a Quote |
| OGA Knockout HeLa Cell Line | EDJ-KQ22105 | Human | 10724 | Details Get a Quote |
| HYAL1 Knockout A-549 Cell Line | EDJ-KQ22258 | Human | 3373 | Details Get a Quote |
| HYAL1 Knockout HCT 116 Cell Line | EDJ-KQ22259 | Human | 3373 | Details Get a Quote |
| CEMIP2 Knockout A-549 Cell Line | EDJ-KQ24339 | Human | 23670 | Details Get a Quote |
| CEMIP2 Knockout HeLa Cell Line | EDJ-KQ24341 | Human | 23670 | Details Get a Quote |
Displaying Records 1 To 15 Of 32 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About hyalurononglucosaminidase activity
What is GO:0004415 hyalurononglucosaminidase activity?
GO:0004415 is a molecular function term describing the catalysis of random hydrolysis of (1->4) linkages between N-acetyl-beta-D-glucosamine and D-glucuronate residues in hyaluronate.
What genes are involved in hyalurononglucosaminidase activity?
Genes such as HYAL1, HYAL2, HYAL3, HYAL4, HYAL5, SPAM1, and CEMIP encode proteins with hyalurononglucosaminidase activity or related functions.
What is the difference between hyaluronidase and hyalurononglucosaminidase?
Hyaluronidase is a broad term for enzymes that degrade hyaluronic acid, while hyalurononglucosaminidase specifically refers to the activity defined by GO:0004415, which randomly hydrolyzes (1->4) linkages.
How is hyalurononglucosaminidase activity measured?
It is commonly measured using turbidimetric, colorimetric, or fluorogenic assays that detect hyaluronan degradation.
What diseases are associated with hyalurononglucosaminidase activity?
Dysregulation is linked to fibrosis, cancer, inflammation, and lysosomal storage disorders.
Can CRISPR be used to study hyalurononglucosaminidase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the function of hyaluronidases.
What are the substrates of hyalurononglucosaminidase?
The primary substrate is hyaluronate, but some enzymes also act on chondroitin sulfate.
Is hyalurononglucosaminidase activity pH-dependent?
Many hyaluronidases exhibit optimal activity at acidic pH, though some are active at neutral pH.
What is the role of hyalurononglucosaminidase in cancer?
It promotes tumor progression by generating hyaluronan fragments that stimulate angiogenesis, inflammation, and metastasis.
How does hyalurononglucosaminidase contribute to fibrosis?
Altered activity leads to imbalanced hyaluronan turnover, contributing to excessive matrix deposition and tissue stiffening.
Conclusion
Hyalurononglucosaminidase activity (GO:0004415) is a fundamental molecular function that governs hyaluronan turnover and extracellular matrix dynamics. Its involvement in fibrosis, cancer, and inflammation makes it a compelling target for therapeutic development. Leveraging CRISPR-based models and advanced omics, researchers can now dissect the precise roles of hyaluronidases in health and disease, paving the way for novel interventions.
References
- 1. Korshunov VA et al.. 2019. Strain-selective efficacy of sacubitril/valsartan on carotid fibrosis in response to injury in two inbred mouse strains.. Br J Pharmacol 176(15):2795-2807 PMID: 31077344
